RELADDIN

EUIPO EUIPO 2011 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark RELADDIN was filed as Word mark on 11/24/2011 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/05/2012. The current status of the mark is "Trademark registered".

Trademark Details Last update: November 9, 2021

Trademark form Word mark
File reference 010442853
Application date November 24, 2011
Publication date March 12, 2012
Entry date July 5, 2012
Expiration date November 24, 2031

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; veterinary preparations; pharmaceutical preparations, none relating to diabetes

Trademark history

Date Document number Area Entry
October 20, 2021 Extension, Trade mark renewed
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Published

ID: 11010442853